GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Other Long Term Assets

Biolife Sciences (Biolife Sciences) Other Long Term Assets : $0.55 Mil (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Other Long Term Assets?

Biolife Sciences's other long-term assets for the quarter that ended in May. 2008 was $0.55 Mil.

Biolife Sciences's quarterly other long-term assets declined from Nov. 2007 ($0.57 Mil) to Feb. 2008 ($0.50 Mil) but then increased from Feb. 2008 ($0.50 Mil) to May. 2008 ($0.55 Mil).

Biolife Sciences's annual other long-term assets declined from Nov. 2005 ($0.35 Mil) to Nov. 2006 ($0.24 Mil) but then increased from Nov. 2006 ($0.24 Mil) to Nov. 2007 ($0.57 Mil).


Biolife Sciences Other Long Term Assets Historical Data

The historical data trend for Biolife Sciences's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Other Long Term Assets Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Other Long Term Assets
- 0.35 0.24 0.57

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.37 0.57 0.50 0.55

Biolife Sciences Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020